Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Information about licenses to be uploaded on online portal SUGAM: Health Ministry Gazette

      Information about licenses to be uploaded on online portal SUGAM: Health Ministry Gazette

      Ruby Khatun Khatun20 July 2018 12:04 PM
      New Delhi: Through a recent gazette notification, the Ministry of Health and Family Welfare has amended the Drugs and Cosmetics Rules, 1945. The...
      Zydus Cadila gets USFDA approval for arthritis drug

      Zydus Cadila gets USFDA approval for arthritis drug

      Ruby Khatun Khatun20 July 2018 6:15 AM
      Zydus Cadila has received the final approval from the United States Food and Drug Administration (USFDA) to market Piroxicam Capsules USP in the...
      Lupin gets USFDA approval for generic erectile dysfunction drug

      Lupin gets USFDA approval for generic erectile dysfunction drug

      Ruby Khatun Khatun20 July 2018 5:15 AM
      New Delhi: Drug firm Lupin said it has received tentative approval from the US health regulator for its Tadalafil tablets, indicated for treating...
      Jiva Ayurveda launches first-ever diagnostic protocols for Ayurveda

      Jiva Ayurveda launches first-ever diagnostic protocols for Ayurveda

      Ruby Khatun Khatun20 July 2018 4:30 AM
      New Delhi: Jiva Ayurveda, a leading and trusted name in Ayurveda, launched first-of-its-kind diagnostic protocols for Ayurveda with the aim to create...
      Bill Gates backs 30 million dollar push for early Alzheimers diagnostics

      Bill Gates backs 30 million dollar push for early Alzheimer's diagnostics

      Ruby Khatun Khatun20 July 2018 4:15 AM
      CHICAGO: Billionaire Bill Gates and Estée Lauder Cos chairman emeritus Leonard Lauder on Tuesday said they will award $30 million over three years to...
      Novartis joins Pfizer in halting US drug price hikes

      Novartis joins Pfizer in halting US drug price hikes

      Ruby Khatun Khatun20 July 2018 4:00 AM
      ZURICH: Novartis expects to hit the top of its 2018 sales guidance after a strong second quarter, the CEO said, despite joining Pfizer in freezing its...
      No Respite: HC pressure mounts of Singh Brothers on Daiichi- Ranbaxy Row

      No Respite: HC pressure mounts of Singh Brothers on Daiichi- Ranbaxy Row

      Ruby Khatun Khatun19 July 2018 10:30 AM
      New Delhi: The Delhi High Court directed former promoters of India's Ranbaxy Laboratories Ltd, Malvinder, and Shivinder Singh, to disclose their bank...
      Sun Pharma gets USFDA approval for cancer injection INFUGEM

      Sun Pharma gets USFDA approval for cancer injection INFUGEM

      Ruby Khatun Khatun19 July 2018 5:15 AM
      New Delhi: Drug major Sun Pharmaceutical Industries said it has received approval from the US health regulator for its INFUGEM injection used for the...
      Zydus Cadila gets USFDA approval to market 4 generic products

      Zydus Cadila gets USFDA approval to market 4 generic products

      Ruby Khatun Khatun19 July 2018 5:00 AM
      New Delhi: Pharma firm Zydus Cadila said it has received final approvals from the US health regulator to market four generic products in America.The...
      Money Laundering Case: ED files charge sheet against Gujarat-based firm director

      Money Laundering Case: ED files charge sheet against Gujarat-based firm director

      Ruby Khatun Khatun19 July 2018 4:45 AM
      New Delhi: The Enforcement Directorate has filed a charge sheet against Gujarat-based pharma firm Sterling Biotech Limited's director Rajbhushan...
      Retailers oppose restrictions on sale of tobacco products with FMCG

      Retailers oppose restrictions on sale of tobacco products with FMCG

      Ruby Khatun Khatun19 July 2018 4:30 AM
      New Delhi: Federation of Retailer Association of India said the Union health ministry's advisory to ban the sale of tobacco products in small shops...
      Mylan signs US license deal on Humira with AbbVie

      Mylan signs US license deal on Humira with AbbVie

      Ruby Khatun Khatun19 July 2018 4:15 AM
      AbbVie Inc said it signed a U.S. licensing deal with Mylan NV for its proposed biosimilar to AbbVie’s blockbuster drug Humira, in a move that will...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok